<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00445653</url>
  </required_header>
  <id_info>
    <org_study_id>CDR0000450146</org_study_id>
    <secondary_id>MGH-1999-P-010929/13</secondary_id>
    <nct_id>NCT00445653</nct_id>
  </id_info>
  <brief_title>Risk Factors for Barrett's Esophagus in Patients With BE, Gastroesophageal Reflux, or Gastrointestinal Bleeding</brief_title>
  <official_title>Molecular Epidemiology of Barrett's Esophagus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      RATIONALE: A study that evaluates DNA changes and other disease-related health information in
      patients with Barrett's esophagus, gastroesophageal reflux, or gastrointestinal bleeding may
      help doctors learn more about the risk factors for Barrett's esophagus.

      PURPOSE: This clinical trial is looking at DNA changes and other disease-related health
      information as risk factors for Barrett's esophagus in patients with Barrett's esophagus,
      gastroesophageal reflux, or gastrointestinal bleeding.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:

        -  Assess the role of several genetically determined factors that, in combination with CagA
           status, cigarette smoking, alcohol, and diet to varying degrees, result in an increased
           risk for Barrett's esophagus.

      OUTLINE: This is a controlled study.

      Patients complete questionnaires about demographics, medical history, smoking and alcohol
      history, current medications, frequency and chronicity of gastroesophageal reflux symptoms,
      and diet history.

      Blood and tissue are collected and analyzed by DNA-based assays and enzyme-linked
      immunosorbent assay for CagA status and polymorphisms in detoxifying enzyme systems, other
      xenobiotic metabolism pathways (e.g., CYP1A1, CYP2E1, CYP3A4, CYP3A5, NQO, NAT-2),
      inflammatory gene pathways (e.g., IGF, IGFBF3), and in DNA repair genes or p53 pathways
      (e.g., XRCC1, p53 gene).

      PROJECTED ACCRUAL: A total of 350 patients will be accrued for this study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2005</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Polymorphisms in detoxifying enzyme systems such as glutathione S-transferases (e.g., mu, theta, pi)</measure>
    <time_frame>2000-2013</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Polymorphisms in other xenobiotic metabolism pathways (e.g., CYP1A1, CYP2E1, CYP3A4/5, NQO1, mEH, NAT-2)</measure>
    <time_frame>2000-2013</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Polymorphisms in inflammatory gene pathways (e.g., MPO, MnSOD, IGF, IGFBF3, Il1-beta)</measure>
    <time_frame>2000-2013</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Polymorphisms in DNA repair genes or the p53 pathways (e.g., ERCC2, XRCC1, p53, p73, CCND1, p21)</measure>
    <time_frame>2000-2013</time_frame>
  </primary_outcome>
  <enrollment type="Actual">170</enrollment>
  <condition>Precancerous Condition</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples only were collected
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients coming in for EGD
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:

          -  Undergoing elective esophagogastroduodenoscopy for any of the following reasons:

               -  Surveillance of Barrett's esophagus

               -  Evaluation of severe or refractory gastroesophageal reflux disease or chest pain
                  thought to be due to reflux

               -  Gastrointestinal bleeding

        PATIENT CHARACTERISTICS:

          -  Not pregnant

        PRIOR CONCURRENT THERAPY:

          -  Not specified
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David C. Christiani, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Massachusetts General Hospital Cancer Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Harvard School of Public Health</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 7, 2007</study_first_submitted>
  <study_first_submitted_qc>March 7, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 9, 2007</study_first_posted>
  <last_update_submitted>January 13, 2017</last_update_submitted>
  <last_update_submitted_qc>January 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>David Christopher Christiani</investigator_full_name>
    <investigator_title>Pulmonary Associate</investigator_title>
  </responsible_party>
  <keyword>Barrett esophagus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
    <mesh_term>Barrett Esophagus</mesh_term>
    <mesh_term>Precancerous Conditions</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

